Can Carbohydrate Antigen-125 Be a New Biomarker to Guide Heart Failure Treatment?: The CHANCE-HF Trial.
Cardiology, Cardio-Thoracic Department, Civil Hospitals, Brescia, Italy.
Antonio
A
D'Aloia
Cardiology, Cardio-Thoracic Department, Civil Hospitals, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Enrico
E
Vizzardi
Cardiology, Cardio-Thoracic Department, Civil Hospitals, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy. Electronic address: metramarco@libero.it.
Marco
M
Metra
D015415:Biomarkers; D018394:CA-125 Antigen; D002241:Carbohydrates; D006333:Heart Failure; D006801:Humans; D020097:Natriuretic Peptide, Brain; D011379:Prognosis
D015415:Biomarkers; D018394:CA-125 Antigen; D002241:Carbohydrates; D020097:Natriuretic Peptide, Brain
CA125; biomarkers; heart failure; prognosis